重组人促红细胞生成素（rHuEPO）治疗癌症相关性贫血：我们学到了什么？ - Suppr

Suppr

超能文献

Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?

作者信息

Osterborg A

机构信息

Department of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm, Sweden.

出版信息

Med Oncol. 1998 Aug;15 Suppl 1:S47-9.

PMID:9785337

Abstract

摘要

相似文献

Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?重组人促红细胞生成素（rHuEPO）治疗癌症相关性贫血：我们学到了什么？

Med Oncol. 1998 Aug;15 Suppl 1:S47-9.

Current thinking and treatment practices in anaemia--an interactive poll.贫血的当前思路与治疗实践——一项互动式民意调查

Med Oncol. 2000 Nov;17 Suppl 1:S32-7.

Alfa-epoietin and anaemia in gynaecological cancer.

Anticancer Res. 2004 Mar-Apr;24(2C):1287-92.

Guidelines for the use of rHuEpo in anaemia of malignancy. Department of Internal Medicine and Medical Therapy, University of Pavia Medical school, Pavia, Italy.重组人促红细胞生成素用于恶性肿瘤贫血的指南。意大利帕维亚大学医学院内科与药物治疗系

Med Oncol. 1998 Aug;15 Suppl 1:S50.

[Use of human recombinant erythropoietin in children with cancer].[重组人促红细胞生成素在患癌儿童中的应用]

Arch Pediatr. 2005 Sep;12(9):1376-82. doi: 10.1016/j.arcped.2005.05.006.

[Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer].[贫血合并癌症患者对重组人促红细胞生成素治疗的预测反应变量]

Medicina (B Aires). 2002;62(1):41-7.

Quality of life in clinical trials: assessment and utility with special reference to rHuEPO.临床试验中的生活质量：特别参考重组人促红细胞生成素的评估与效用

Med Oncol. 1998 Aug;15 Suppl 1:S8-12.

Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.恶性肿瘤患者贫血的机制：对重组人促红细胞生成素临床应用的启示

Med Oncol. 2000 Nov;17 Suppl 1:S11-6.

Assessing the impact of cancer-related anaemia on quality of life and the role of rHuEPO.评估癌症相关性贫血对生活质量的影响以及重组人促红细胞生成素的作用。

Med Oncol. 2000 Nov;17 Suppl 1:S23-31.

Role of epoetin in the management of anaemia in patients with lung cancer.促红细胞生成素在肺癌患者贫血管理中的作用。

Lung Cancer. 2004 Nov;46(2):149-56. doi: 10.1016/j.lungcan.2004.04.034.

引用本文的文献

Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study.PERFORM 问卷在评估癌症合并贫血患者乏力中的作用：一项前瞻性观察研究。

Support Care Cancer. 2013 Nov;21(11):3039-49. doi: 10.1007/s00520-013-1862-z. Epub 2013 Jun 22.

Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.化疗引起的贫血的癌症患者在基线血红蛋白水平<9 g/dL 时起始使用达贝泊汀α治疗与 9 至<10 g/dL 时起始治疗与≥10 g/dL 时起始治疗的输血风险：一项 3 期试验的探索性分析。

Med Oncol. 2012 Sep;29(3):2291-9. doi: 10.1007/s12032-011-0103-x. Epub 2011 Nov 13.

The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.贫血癌症治疗（A.C.T.）研究的背景与方法：一项关于癌症患者贫血管理实践模式及结果的全球回顾性研究，以及这些模式与循证指南的一致性。

Support Care Cancer. 2008 Feb;16(2):193-200. doi: 10.1007/s00520-007-0311-2. Epub 2007 Sep 14.

Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.自体干细胞移植前给予重组人促红细胞生成素α可减少多发性骨髓瘤患者的输血需求。

Support Care Cancer. 2005 Mar;13(3):182-7. doi: 10.1007/s00520-004-0686-2. Epub 2004 Oct 6.

Reticulocytes and reticulocyte enumeration.网织红细胞与网织红细胞计数

J Clin Lab Anal. 2001;15(5):267-94. doi: 10.1002/jcla.1039.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验